TCI Wealth Advisors’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-436
Closed -$4K 2430
2022
Q1
$4K Buy
436
+165
+61% +$1.82K ﹤0.01% 1736
2021
Q4
$4K Buy
271
+123
+83% +$2.31K ﹤0.01% 1852
2021
Q3
$3K Buy
+148
New +$3.56K ﹤0.01% 1964
2021
Q2
Sell
-79
Closed -$3K 2399
2021
Q1
$3K Buy
+79
New +$1.92K ﹤0.01% 1550

Other funds holding MGNX

TCI Wealth Advisors's MGNX Position: Q2 2022 in Review

TCI Wealth Advisors sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 436 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in MGNX in Q1 2021 and held it in 4 quarters. The position peaked at $4K in Q1 2022. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

  • TCI Wealth Advisors reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 436 MacroGenics shares in Q2 2022, an estimated $4K.
  • TCI Wealth Advisors first reported a position in MacroGenics in Q1 2021 and held it in 4 quarters.
  • TCI Wealth Advisors's MacroGenics position peaked at $4K in Q1 2022.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.